Illumina (ILMN)
(Delayed Data from NSDQ)
$130.14 USD
+2.41 (1.89%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $130.17 +0.03 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 36% (90 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.26 | 1.35 | 9.99 |
Current Quarter Estimate | 0.03 | 7.43 | 59.00 |
Year Ago Quarter Estimate | 0.08 | 0.12 | 50.37 |
Next Quarter Estimate | 0.18 | 7.81 | 60.00 |
Next Year Estimate | 2.39 | 37.76 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8.14 | 12.40 | 20.73 |
Next Year | 156.99 | 12.20 | 13.55 |
Last 5 Years | -31.50 | 1.00 | 9.00 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 149.59 | -2.18 |
Price/Book (MRQ) | 3.60 | 2.16 |
Price/Cash Flow (MRFY) | 36.32 | 14.21 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -25.78% | -133.34% |
Return on Equity (TTM) | 2.20% | -49.84% |
Debt to Equity (MRQ) | 0.26 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.